Literature DB >> 14596812

Nutritional status in the neuroendocrine control of growth hormone secretion: the model of anorexia nervosa.

Massimo Scacchi1, Angela Ida Pincelli, Francesco Cavagnini.   

Abstract

Growth hormone (GH) plays a key role not only in the promotion of linear growth but also in the regulation of intermediary metabolism, body composition, and energy expenditure. On the whole, the hormone appears to direct fuel metabolism towards the preferential oxidation of lipids instead of glucose and proteins, and to convey the energy derived from metabolic processes towards the synthesis of proteins. On the other hand, body energy stores and circulating energetic substrates take an important part in the regulation of somatotropin release. Finally, central and peripheral peptides participating in the control of food intake and energy expenditure (neuropeptide Y, leptin, and ghrelin) are also involved in the regulation of GH secretion. Altogether, nutritional status has to be regarded as a major determinant in the regulation of the somatotropin-somatomedin axis in animals and humans. In these latter, overweight is associated with marked impairment of spontaneous and stimulated GH release, while acute dietary restriction and chronic undernutrition induce an amplification of spontaneous secretion together with a clear-cut decrease in insulin-like growth factor I (IGF-I) plasma levels. Thus, over- and undernutrition represent two conditions connoted by GH hypersensitivity and GH resistance, respectively. Anorexia nervosa (AN) is a psychiatric disorder characterized by peculiar changes of the GH-IGF-I axis. In these patients, low circulating IGF-I levels are associated with enhanced GH production rate, highly disordered mode of somatotropin release, and variability of GH responsiveness to different pharmacological challenges. These abnormalities are likely due not only to the lack of negative IGF-I feedback, but also to a primary hypothalamic alteration with increased frequency of growth hormone releasing hormone discharges and decreased somatostatinergic tone. Given the reversal of the above alterations following weight recovery, these abnormalities can be seen as secondary, and possibly adaptive, to nutritional deprivation. The model of AN may provide important insights into the pathophysiology of GH secretion, in particular as regards the mechanisms whereby nutritional status effects its regulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14596812     DOI: 10.1016/s0091-3022(03)00014-1

Source DB:  PubMed          Journal:  Front Neuroendocrinol        ISSN: 0091-3022            Impact factor:   8.606


  17 in total

1.  Development of acromegaly in a patient with anorexia nervosa: pathogenetic and diagnostic implications.

Authors:  E de Menis; M Gola; A Giustina
Journal:  J Endocrinol Invest       Date:  2006-10       Impact factor: 4.256

Review 2.  Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa.

Authors:  A Torsello; F Brambilla; L Tamiazzo; I Bulgarelli; D Rapetti; E Bresciani; V Locatelli
Journal:  J Endocrinol Invest       Date:  2007-12       Impact factor: 4.256

3.  Severe acute malnutrition in childhood: hormonal and metabolic status at presentation, response to treatment, and predictors of mortality.

Authors:  Sarah Bartz; Aaloke Mody; Christoph Hornik; James Bain; Michael Muehlbauer; Tonny Kiyimba; Elizabeth Kiboneka; Robert Stevens; John Bartlett; John V St Peter; Christopher B Newgard; Michael Freemark
Journal:  J Clin Endocrinol Metab       Date:  2014-02-27       Impact factor: 5.958

4.  Chronic treatment with either dexfenfluramine or sibutramine in diet-switched diet-induced obese mice.

Authors:  Eugene N Bush; Robin Shapiro; Michael E Brune; Victoria E Knourek-Segel; Brian A Droz; Thomas Fey; Emily Lin; Peer B Jacobson
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

Review 5.  Does the pituitary somatotrope play a primary role in regulating GH output in metabolic extremes?

Authors:  Raul M Luque; Manuel D Gahete; Jose Cordoba-Chacon; Gwen V Childs; Rhonda D Kineman
Journal:  Ann N Y Acad Sci       Date:  2011-03       Impact factor: 5.691

6.  Mice with infectious colitis exhibit linear growth failure and subsequent catch-up growth related to systemic inflammation and IGF-1.

Authors:  Mark D DeBoer; Vidhya Vijayakumar; Meiqing Gong; John L Fowlkes; Rachel M Smith; Fernando Ruiz-Perez; James P Nataro
Journal:  Nutr Res       Date:  2017-02-07       Impact factor: 3.315

Review 7.  Ghrelin receptor signaling: a promising therapeutic target for metabolic syndrome and cognitive dysfunction.

Authors:  Wei-na Cong; Erin Golden; Nick Pantaleo; Caitlin M White; Stuart Maudsley; Bronwen Martin
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-11       Impact factor: 4.388

8.  Growth hormone deficiency and cerebral palsy.

Authors:  Jesús Devesa; Nerea Casteleiro; Cristina Rodicio; Natalia López; Pedro Reimunde
Journal:  Ther Clin Risk Manag       Date:  2010-09-07       Impact factor: 2.423

9.  The influence of nutrition on the insulin-like growth factor system and the concentrations of growth hormone, glucose, insulin, gonadotropins and progesterone in ovarian follicular fluid and plasma from adult female horses (Equus caballus).

Authors:  Juan Salazar-Ortiz; Philippe Monget; Daniel Guillaume
Journal:  Reprod Biol Endocrinol       Date:  2014-07-31       Impact factor: 5.211

10.  Ghrelin resistance occurs in severe heart failure and resolves after heart transplantation.

Authors:  Lars H Lund; Jill J Williams; Pamela Freda; John J LaManca; Thierry H LeJemtel; Donna M Mancini
Journal:  Eur J Heart Fail       Date:  2009-06-25       Impact factor: 15.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.